REDHILL BIOPHARMA LTD is associated with UEI NKN1XZ8D6KG5 and CAGE 2967A in public federal records. AcornBids currently links 1 prime award totaling $733.4K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists TEL AVIV-JAFFA, ISR.
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 30, 2026. Refresh pending; these totals may be out of date.
Public SAM.gov registration details.
Source facts
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 1 of 1 selected awards. Select a period to explore its awards.
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75A50124C00059REDHILL BIOPHARMA LTD-OPAGANIB AS HOST-DIRECTED THERAPEUTIC FOR EBOLA VIRUS DISEASE | Department of Health and Human Services | $733.4K | Sep 27, 2024 | Mar 31, 2026 |
| Registration evidence | Date |
|---|---|
| SAM updated | Dec 2, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Jul 6, 2011 |
| Entity start | Aug 3, 2009 |
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| RAZI INGBER | Government business | Contact method not published | SAM registration | Not available |
| REZA FATHI | Electronic business | Contact method not published | SAM registration | Not available |
| ADI FRISH | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Ownership follows reported parent UEIs.
Reported ownership links. Award and funding explorers can include this family.
| Legal entity | Reported parent UEI | Source loaded |
|---|---|---|
| REDHILL BIOPHARMA LTD | NKN1XZ8D6KG5 | Sep 26, 2026 |
| REDHILL BIOPHARMA, INC. | NKN1XZ8D6KG5 | Sep 26, 2026 |
Explore the customer, work and award-size evidence behind each match.
Recorded award industries: 541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Recorded products and services: AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT.
Examples from recent award records:
These records describe federal award work, not every company capability. Review the award evidence.
21 HAARBAA STREET, TEL AVIV-JAFFA 64739, ISR
Registered location from SAM.gov; award performance locations may differ.
541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Primary SAM.gov NAICS classification.
Department of Health and Human Services.
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit